Efficacy and Safety on the Use of Bisphosphonates in Paediatrics
NCT04012320 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99
Last updated 2019-07-09
Summary
The investigators suppose that the impact of bisphosphonate therapy is beneficial on the bone during the growth period with few adverse events.
Conditions
- Bone Fragile
- Bisphosphonate-Associated Osteonecrosis
- Children
- Adverse Events
Interventions
- OTHER
-
No intervention, observational study
No intervention, observational study
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Nīmes
lead OTHER
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-31
- Primary Completion
- 2018-12-31
- Completion
- 2018-12-31
Countries
- France
Study Locations
More Related Trials
-
Impact of Oral Phosphorus Supplements on the 6-month Change in FGF23 Levels in Anorexic Adolescents Suffering From Undernutrition.
NCT02812134 ·Status: UNKNOWN
-
Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome
NCT02713945 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study
NCT03709381 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study in Children With Achondroplasia
NCT07301463 ·Status: RECRUITING
-
Growth Hormone Therapy in Osteogenesis Imperfecta
NCT00001305 ·Status: COMPLETED ·Phase: PHASE3
-
Growth Hormone Therapy and Bone Quality in Pediatric Osteoporosis
NCT00757393 ·Status: COMPLETED ·Phase: PHASE3
-
Extension Study of Protocol ENB-006-09 - Study of Asfotase Alfa in Children With Hypophosphatasia (HPP)
NCT01203826 ·Status: COMPLETED ·Phase: PHASE2
-
A UK Multicentre, Health-Related Quality of Life Study for Children and Adolescents With XLH
NCT04819490 ·Status: COMPLETED
-
A Study to Describe the Lived Experience of XLH for Adolescents at End of Skeletal Growth
NCT05181839 ·Status: COMPLETED
-
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SAR442501 in Pediatric Participants With Achondroplasia
NCT06067425 ·Status: TERMINATED ·Phase: PHASE2
-
Diagnosis of Short Stature in Children : Study of a Cohort of Small-sized Consulting Patients
NCT04754516 ·Status: COMPLETED
-
Boost Brittle Bones Before Birth
NCT03706482 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age) Short Stature That Are Still Growing
NCT01110928 ·Status: COMPLETED
-
A Single Dose Study to Evaluate the PK-PD Response and Safety of PHA-794428 in Children With Growth Hormone Deficiency
NCT00314938 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency
NCT01502124 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacodynamics of CNP During Growth Hormone Treatment
NCT01504802 ·Status: COMPLETED
-
Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome
NCT03383380 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Biological Age in Children With GH Deficiency Undergoing Hormone Replacement Therapy
NCT06294860 ·Status: COMPLETED
-
Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA)
NCT01859949 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Study of Growth Hormone on Bone Mineral Density in Patients With Adult Onset Growth Hormone Deficiency
NCT00006394 ·Status: COMPLETED ·Phase: NA
-
Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia.
NCT03794609 ·Status: TERMINATED
-
Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys
NCT00133354 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Treatment of Children With Insufficient Secretion of Growth Hormone
NCT00271518 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of Anorexia Nervosa on Bone Mass in Adolescents
NCT00088153 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Three-times-weekly Versus Daily Growth Hormone (GH) Treatment in naïve GH-deficient Children
NCT03033121 ·Status: COMPLETED ·Phase: PHASE3